Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Karyopharm Therapeutics Inc. buy me8

Start price
05.02.24 / 0%
Target price
Performance (%)
End price
This prediction ended on 06.02.24 with a price of €1.75. The prediction had a final performance of 29.34%. This prediction was marked as speculative and is excluded from me8's performance statistics.
Performance without dividends (%)
Name 1w
Karyopharm Therapeutics Inc. -4.185%
iShares Core DAX® 1.839%
iShares Nasdaq 100 1.873%
iShares Nikkei 225® 1.937%
iShares S&P 500 0.764%

According to me8 what are the pros and cons of Karyopharm Therapeutics Inc. for the foreseeable future?

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Few uniques

Comments by me8 for this prediction

In the thread Karyopharm Therapeutics Inc. diskutieren

Buy Karyopharm Therapeutics Inc.

In the thread Trading Karyopharm Therapeutics Inc.
Prediction Buy
Perf. (%) 29.34%
Target price
Ends at 05.02.25

Buy beendet